Advances in MRD Testing for Informed CRC Treatment : Episode 11
Myths Surrounding Liquid Biopsy and ctDNA Testing for MRD
Pashtoon Murtaza Kasi, MD, MS, emphasizes key aspects of liquid biopsy and ctDNA testing in the MRD treatment landscape.
EP: 1.Treating Colorectal Cancer: Overview of MRD Testing and ctDNA
EP: 2.When is MRD Testing Performed in Colorectal Cancer Treatment?
EP: 3.MRD Testing Platforms in Colorectal Cancer
EP: 4.Testing for MRD in Colorectal Cancer
EP: 5.Colorectal Cancer: MRD Testing in the Community Setting
EP: 6.Practical Considerations in MRD Testing in CRC
EP: 7.Evolution of MRD Testing in Colorectal Cancer
EP: 8.Patient Profile: A 52-Year-Old Woman With Colorectal Cancer
EP: 9.Colorectal Cancer: Updates from the GALAXY Arm in CIRCULATE-Japan
EP: 10.BESPOKE CRC: Study of ctDNA-Guided Therapy in Colorectal Cancer
Now Viewing
EP: 11.Myths Surrounding Liquid Biopsy and ctDNA Testing for MRD
EP: 12.Patient Profile 2: A 35-Year-Old Man With Oligometastatic Colorectal Cancer
EP: 13.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer
EP: 14.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer: Part 2
EP: 15.CIRCULATE-NORTH AMERICA and Barriers to Enrollment
EP: 16.MRD Testing in CRC: Gaps in our Understanding and Potential Advancements
EP: 17.Trajectory of CRC Treatment Landscape
Related Videos
Related Content
